Comments on: Paclitaxel by Fulgent Pharma for Paranasal Sinus And Nasal Cavity Cancer: Likelihood of Approval /data-insights/paclitaxel-fulgent-pharma-paranasal-sinus-and-nasal-cavity-cancer-likelihood-of-approval/ The leading site for news and procurement in the pharmaceutical industry Mon, 09 Sep 2024 06:08:17 +0000 hourly 1 https://wordpress.org/?v=6.7.1